ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,911Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 5176

$3.26M Total Retail Price of All Prescriptions

Rank: 9 out of 5176

531 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 531 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 531 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 28,317 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

55% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$109 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 1,610 1,535 1 16
ATENOLOL 746 672 2 12
LIPITOR 696 663 10 3 51
ZOLPIDEM TARTRATE 683 662 4 17
METFORMIN HCL 566 502 5 7
CRESTOR 564 547 6 15
SYNTHROID 555 519 7 33
AMLODIPINE BESYLATE 537 511 8 2
NIFEDIPINE ER 526 517 9 48
TAMSULOSIN HCL 436 419 10 20
CELEBREX 431 404 11 80
ATORVASTATIN CALCIUM 430 403 12 9
METOPROLOL TARTRATE 406 382 13 6
PLAVIX 374 363 14 29
SIMVASTATIN 370 344 15 1
METOPROLOL SUCCINATE 362 347 16 11
ADVAIR DISKUS 352 348 17 32
LIDODERM 341 331 18 59
LOVAZA 329 323 19 43
RANEXA 328 328 20 167
FUROSEMIDE 305 302 21 8
DIOVAN 299 271 22 19
ISOSORBIDE MONONITRATE ER 290 288 23 44
JANUVIA 270 263 24 25
POTASSIUM CHLORIDE 261 252 25 34
ACETAMINOPHEN-CODEINE 236 213 S3 26 127
GLIMEPIRIDE 231 208 27 37
NAMENDA 227 226 28 47
BENICAR 225 220 29 100
NASONEX 225 206 29 178
CREON 222 216 31 111
POLYETHYLENE GLYCOL 3350 220 219 32 74
SINGULAIR 219 219 33 62
LISINOPRIL 219 182 33 5
MECLIZINE HCL 218 211 35 81
TOPROL XL 214 204 36 227
COUMADIN 212 211 37 112
DONEPEZIL HCL 209 209 38 28
BENICAR HCT 201 201 39 110
SPIRIVA 197 197 40 54
OMEPRAZOLE 196 189 41 3
LEXAPRO 192 192 42 193
ONGLYZA 190 158 43 153
PROAIR HFA 190 188 43 60
DIOVAN HCT 178 178 45 39
TRAMADOL HCL 174 160 46 40
NITROGLYCERIN PATCH 171 170 47 149
TORSEMIDE 167 155 48 184
DICYCLOMINE HCL 166 152 49 224
DEXILANT 162 144 50 118
CLOTRIMAZOLE-BETAMETHASONE 162 155 50 94
CARVEDILOL 161 156 52 24
GABAPENTIN 156 144 53 21
LOSARTAN POTASSIUM 156 124 53 14
AZITHROMYCIN 149 136 55 42
AVODART 142 142 56 107
MICARDIS HCT 139 131 57 180
HYDROCHLOROTHIAZIDE 135 112 58 10
LOSARTAN-HYDROCHLOROTHIAZIDE 134 132 59 35
IBUPROFEN 134 124 59 72
PRAMIPEXOLE DIHYDROCHLORIDE 131 130 61 339
AMBIEN 129 129 10 62 508
TRIAMTERENE-HCTZ 128 124 63 86
LUNESTA 125 116 64 242
PROCTOZONE-HC 119 117 65 171
GLYBURIDE 118 100 R 66 67
AMMONIUM LACTATE 118 105 66 91
CLOPIDOGREL 116 116 68 26
ALENDRONATE SODIUM 116 93 68 18
ASTEPRO 113 108 70 378
MICARDIS 113 112 70 154
VOLTAREN 111 106 72 97
BONIVA 109 105 73 236
CARBIDOPA-LEVODOPA 108 108 74 98
PATANOL 107 107 75 158
NITROSTAT 106 105 76 205
LACTULOSE 104 97 77 87
CIPROFLOXACIN HCL 104 96 77 84
ESCITALOPRAM OXALATE 103 103 79 89
PREDNISONE 101 76 80 52
RAPAFLO 99 99 81 362
SERTRALINE HCL 99 80 81 30
ENALAPRIL MALEATE 98 98 83 22
LEVOTHYROXINE SODIUM 98 83 83 4
DOVONEX 97 84 85 554
FINASTERIDE 93 93 86 69
CLONIDINE HCL 92 91 87 79
FAMOTIDINE 91 90 88 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 80 89 49
LANSOPRAZOLE 84 76 90 113
FLUTICASONE PROPIONATE 79 73 91 38
ALLOPURINOL 79 78 91 41
SEROQUEL 78 75 93 166
HYZAAR 77 77 10 94 633
COMBIVENT 76 76 95 156
MELOXICAM 75 73 96 53
ELIDEL 75 70 10 96 635
AMLODIPINE BESYLATE-BENAZEPRIL 72 72 98 55
LOPERAMIDE 71 71 99 329
LEVOXYL 71 71 99 238
LEVOFLOXACIN 70 68 101 109
RAMIPRIL 70 67 101 50
CALCITRIOL 70 70 101 261
LANTUS 69 69 104 66
CYMBALTA 69 47 104 90
FOSINOPRIL SODIUM 68 68 106 105
TRAZODONE HCL 68 65 106 71
COLCRYS 68 68 106 170
DILTIAZEM 24HR CD 67 66 109 119
TRIAMCINOLONE ACETONIDE 66 63 110 125
RANITIDINE HCL 66 54 110 36
AMITIZA 66 66 110 197
WARFARIN SODIUM 62 46 113 13
OXYCODONE-ACETAMINOPHEN 62 51 S2 113 101
SOLARAZE 62 61 113 157
ONDANSETRON HCL 61 51 116 570
AGGRENOX 59 54 117 235
FLOMAX 58 58 10 118 681
PRANDIN 56 56 119 150
SPIRONOLACTONE 56 56 119 88
KETOCONAZOLE 56 48 119 233
RISPERIDONE 56 56 119 78
FLECTOR 55 48 123 282
SYMBICORT 54 45 124 120
OXYBUTYNIN CHLORIDE 54 45 124 227
KLOR-CON 10 53 53 126 225
HYDROCODONE-ACETAMINOPHEN 53 50 S3 126 27
FLUOCINONIDE 53 49 126 165
CILOSTAZOL 53 50 126 206
ZOCOR 52 52 10 130 710
DIGOXIN 52 48 130 56
BYSTOLIC 52 49 130 96
PAROXETINE HCL 51 48 133 93
ZOVIRAX 51 51 133 313
HALOBETASOL PROPIONATE 51 46 133 445
LATANOPROST 51 51 133 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.